You won’t believe this… ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

dylan-diary-email-header-btm

You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here.

Dear Reader,

Good morning. Happy Tuesday!

I am super pumped about our webinar today, because at 1:00pm eastern we are going to talk about one of the most interesting and exciting things the Trump administration has done.

If you haven’t received your private link to join yet, click here to register and we’ll send you one.

Here’s what we’re seeing:

A law is being pushed through Congress right now - RFK Jr. and the Trump administration are about to mandate an AI overhaul that will completely remake this country’s drug testing process…

Replacing old, slow animal testing with faster, more accurate AI testing.

This means a mega change forced on 6,500+ companies around the world that sell pharmaceuticals in the United States.

This is a big deal.

And if you’ve been around a while, you know I’ve been following AI in healthcare for years…

And as this mandate passes into law, as soon as THIS FRIDAY…

The little-known AI companies with the technology all 6,500 drugmakers will be forced to use…

Stand to become huge winners. 

These could be millionaire makers as every one of these pharma companies is legally required to replace animal testing with AI solutions.

This is such an exciting time for me as a biotech investor.

To give you an idea of how revolutionary this is, here’s some facts:

We’ve discovered about 10,000 diseases since the beginning of man…

Liver disease, leukemia, Parkinson’s, Huntington’s, hepatitis… the list goes on and on.

But what most people don’t know is that since the beginning of time, we’ve only invented 500 cures of all those diseases.

That’s 5%.

So, basically 95% of all these diseases not only don’t have cures…

They don’t even have really great ways of managing them.

One problem is, the average drug takes 12 years and $2.6 billion to get to market, from testing to approval.

It’s astonishing how expensive it is.

And a lot of that is in the early stage…

Finding the molecules in the compounds to test in humans…

When we find a compound, if we have an inhibitor, a drug that stops it, how do we attach it to the liver or the certain type of T-cell?

How do we get these things to connect?

These are very complicated chemistry problems.

But AI is really good at these kinds of things.

AI discovered a new potential treatment for liver cancer in 30 days.

Or, think about brain cancer. 

Survival rates for childhood brain cancer haven’t changed in 50 years. 

But AI discovered a potential new treatment for it in just 24 hours.

Take multiple myeloma…

The biotech industry has been working on this for at least 20 years.

But AI found a new treatment in just four months.

These are radical and amazing breakthroughs.

Henry Kissinger wrote a book before he died on how AI is going to revolutionize healthcare, warfare, a bunch of things.

One of the things he said in his book that I found very interesting was, AI has been playing chess in simulations…

And AI invented a chess move that no human had ever considered in a thousand years.

Think about that. Think of all the grand masters that have ever played chess.

It’s remarkable, really.

And this AI invented a totally new move.

His point was that this pattern recognition in machine learning, this “intelligence,” is able to see things in ways humans have not been able to perceive yet.

One of the things it’s really good at is looking at the human body, and at the vast number of drugs, molecules, chemicals, and using blunt force computing power to match which drugs or chemicals might work best attacking which diseases in the body.

We have a limitless computer doing this. It’s a big deal.

This is a moment in history.

I have a dear friend who’s a diehard liberal - I forgive him his folly - he’s always laughing at the MAHA movement - Make America Healthy Again.

And from one perspective, it’s easy to laugh at - I get it.

But this is like real life Star Trek. 

Remember when, no matter what the problem was with a person on the ship, Bones would just give ‘em a little shot and, okay, you’re fine now?

Well, we’re talking about Star Trek stuff here.

It’s outrageous. 

This is what I want to talk to you about today at our 1:00pm webinar (eastern).

I want to show you the research we’ve been compiling.

It’s free to attend.

I also want to show you the AI leaders at the top of my list…

The stocks of the two companies leading this race.

One is backed by NVIDIA in a huge way..

The other by Bill Gates.

And starting as soon as this Friday, these two companies could find themselves in a position where all of a sudden 6,500 companies worldwide are forced to subscribe and buy their AI drug discovery services.

We are on the cusp of an opportunity that comes once in a generation.

I hope you join us.

This is real deal stuff.

One of our members, Harold W. I know won’t be able to join us - he’s undergoing surgery so I want to wish him a speedy recovery and let you know, Harold, you are in our prayers today.

I hope to see everyone else at 1:00pm eastern.

Click here to get your private join link before it starts.

"The Buck Stops Here"

youtube button
facebook button
instagram button

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431


Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.

Behind the Markets


Unsubscribe